Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREPROSTINIL Cause Device information output issue? 141 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 141 reports of Device information output issue have been filed in association with TREPROSTINIL (TYVASO). This represents 0.2% of all adverse event reports for TREPROSTINIL.

141
Reports of Device information output issue with TREPROSTINIL
0.2%
of all TREPROSTINIL reports
3
Deaths
33
Hospitalizations

How Dangerous Is Device information output issue From TREPROSTINIL?

Of the 141 reports, 3 (2.1%) resulted in death, 33 (23.4%) required hospitalization, and 1 (0.7%) were considered life-threatening.

Is Device information output issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 141 reports have been filed with the FAERS database.

What Other Side Effects Does TREPROSTINIL Cause?

Dyspnoea (16,348) Headache (14,051) Diarrhoea (11,335) Nausea (10,320) Cough (8,945) Fatigue (7,440) Dizziness (7,405) Infusion site pain (5,169) Vomiting (5,097) Death (4,764)

What Other Drugs Cause Device information output issue?

SOMATROPIN (5,220) ALBUTEROL (318) CARBIDOPA\LEVODOPA (14) INSULIN ASPART (10) DEVICE (9) BUDESONIDE\FORMOTEROL (7) ETANERCEPT (7) NOREPINEPHRINE (6) BACLOFEN (5) ESTRADIOL (5)

Which TREPROSTINIL Alternatives Have Lower Device information output issue Risk?

TREPROSTINIL vs TREPROSTINIL DIOLAMINE TREPROSTINIL vs TRETINOIN TREPROSTINIL vs TRIAMCINOLONE TREPROSTINIL vs TRIAMCINOLONE ACETONIDE TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE

Related Pages

TREPROSTINIL Full Profile All Device information output issue Reports All Drugs Causing Device information output issue TREPROSTINIL Demographics